NervGen Pharma (NGENF) Short Interest Ratio & Short Volume $2.44 -0.03 (-1.21%) As of 02:04 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock NervGen Pharma Short Interest DataNervGen Pharma (NGENF) has a short interest of 839,700 shares. This marks a -0.39% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.3, indicating that it would take 4.3 days of the average trading volume of 136,343 shares to cover all short positions.Current Short Interest839,700 sharesPrevious Short Interest843,000 sharesChange Vs. Previous Month-0.39%Dollar Volume Sold Short$2.45 millionShort Interest Ratio4.3 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares61,770,000 sharesPercentage of Shares Shorted1.36%Today's Trading Volume30,185 sharesAverage Trading Volume136,343 sharesToday's Volume Vs. Average22% Short Selling NervGen Pharma? Sign up to receive the latest short interest report for NervGen Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNGENF Short Interest Over TimeNGENF Days to Cover Over TimeNGENF Percentage of Float Shorted Over Time NervGen Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025839,700 shares $2.45 million -0.4%N/A4.3 $2.91 6/30/2025843,000 shares $2.12 million -4.9%1.4%4.5 $2.52 6/15/2025886,600 shares $2.42 million +20.4%1.4%0.8 $2.73 5/31/2025736,600 shares $2.70 million +117.9%1.2%0.7 $3.66 5/15/2025338,000 shares $970.03 thousand +18.4%0.5%1.2 $2.87 4/30/2025285,400 shares $620.17 thousand -9.8%N/A2.8 $2.17 4/15/2025316,500 shares $680.48 thousand +10.5%0.5%1.5 $2.15 3/31/2025286,400 shares $572.80 thousand +3.7%0.5%2.5 $2.00 3/15/2025276,200 shares $524.78 thousand +2.2%0.4%2.9 $1.90 2/28/2025270,300 shares $517.62 thousand -2.8%0.4%2.5 $1.92 Get the Latest News and Ratings for NGENF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NervGen Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/2025278,000 shares $581.02 thousand +1.1%0.5%4.5 $2.09 1/31/2025275,100 shares $539.88 thousand -19.4%N/A2.9 $1.96 1/15/2025341,400 shares $716.94 thousand -6.7%N/A2.6 $2.10 12/31/2024366,000 shares $797.88 thousand +37.2%N/A1.6 $2.18 12/15/2024266,800 shares $506.92 thousand -0.9%N/A3 $1.90 11/30/2024269,200 shares $545.13 thousand -4.2%N/A2.5 $2.03 11/15/2024281,100 shares $410.41 thousand +4.0%N/A1.6 $1.46 10/31/2024270,200 shares $470.15 thousand -3.6%N/A2.6 $1.74 10/15/2024280,200 shares $504.36 thousand +2.8%N/A3 $1.80 9/30/2024272,700 shares $518.13 thousand +2.1%N/A4.3 $1.90 9/15/2024267,200 shares $502.34 thousand -0.3%N/A2.7 $1.88 8/31/2024268,000 shares $557.44 thousand -1.1%N/A4.8 $2.08 8/15/2024270,900 shares $574.04 thousand -0.3%N/A2.9 $2.12 7/31/2024271,700 shares $562.42 thousand -28.0%N/A4.6 $2.07 7/15/2024377,500 shares $856.93 thousand +10.7%N/A1.7 $2.27 6/30/2024340,900 shares $674.98 thousand -10.0%N/A2.1 $1.98 6/15/2024378,700 shares $640.00 thousand +27.8%N/A1.5 $1.69 5/31/2024296,400 shares $423.85 thousand +5.3%N/A1.5 $1.43 5/15/2024281,500 shares $433.51 thousand +1.9%N/A3.7 $1.54 4/30/2024276,400 shares $420.13 thousand +301.2%N/A2.9 $1.52 4/15/202468,900 shares $103.35 thousand -83.5%N/A0.6 $1.50 3/31/2024416,300 shares $670.24 thousand +67.8%N/A1.3 $1.61 3/15/2024248,100 shares $474.07 thousand +151.4%N/A2.3 $1.91 2/29/202498,700 shares $251.69 thousand +296.4%N/A0.9 $2.55 2/15/202424,900 shares $63.41 thousand +38.3%N/A0.1 $2.55 1/15/202444,600 shares $88.09 thousand -1.8%N/A0.3 $1.98 12/31/202345,400 shares $92.62 thousand +1,791.7%N/A0.2 $2.04 12/15/20232,400 shares $2.96 thousand +700.0%N/A0 $1.23 11/30/2023300 shares $393.00 -96.0%N/A0 $1.31 11/15/20237,400 shares $10.57 thousand +13.9%N/A0.1 $1.43$100 Trillion “AI Metal” Found in American Ghost Town (Ad)Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.Click here to get the details on this virtual monopoly. 10/31/20236,500 shares $8.71 thousand +333.3%N/A0.1 $1.34 10/15/20231,500 shares $1.94 thousand -81.9%N/A0 $1.30 9/30/20238,300 shares $11.72 thousand +6.4%N/A0.2 $1.41 9/15/20237,800 shares $11.93 thousand -57.1%N/A0.1 $1.53 8/31/202318,200 shares $27.61 thousand +237.0%N/A0.2 $1.52 8/15/20235,400 shares $7.16 thousand -79.6%N/A0.1 $1.33 7/31/202326,500 shares $34.19 thousand +6.4%N/A1 $1.29 7/15/202324,900 shares $32.62 thousand -2.7%N/A0.8 $1.31 6/30/202325,600 shares $31.74 thousand -20.0%N/A0.4 $1.24 6/15/202332,000 shares $41.60 thousand -32.9%N/A1.2 $1.30 5/31/202347,700 shares $62.01 thousand +166.5%N/A1.1 $1.30 5/15/202317,900 shares $20.94 thousand +96.7%N/A0.4 $1.17 4/30/20239,100 shares $10.56 thousand -50.5%N/A0.1 $1.16 4/15/202318,400 shares $24.38 thousand +318.2%N/A0.4 $1.33 3/31/20234,400 shares $5.43 thousand +7.3%N/A0.1 $1.23 3/15/20234,100 shares $5.10 thousand -33.9%N/A0.1 $1.25 2/28/20236,200 shares $8.56 thousand +463.6%N/A0.1 $1.38 2/15/20231,100 shares $1.61 thousand -38.9%N/A0 $1.46 1/31/20231,800 shares $2.91 thousand +200.0%N/A0 $1.62 1/15/2023600 shares $864.00 -83.8%N/A0 $1.44 12/30/20223,700 shares $4.40 thousand +516.7%N/A0.1 $1.19 12/15/2022600 shares $720.00 -81.8%N/A0 $1.20 11/30/20223,300 shares $4.69 thousand -13.2%N/A0.1 $1.42 11/15/20223,800 shares $4.96 thousand +111.1%N/A0.1 $1.31 10/31/20221,800 shares $2.36 thousand -56.1%N/A0.1 $1.31 10/15/20224,100 shares $5.08 thousand -73.6%N/A0.1 $1.24 9/30/202215,500 shares $20.77 thousand +453.6%N/A0.2 $1.34 9/15/20222,800 shares $4.13 thousand -42.9%N/A0.1 $1.47 8/31/20224,900 shares $7.40 thousand No ChangeN/A0.1 $1.51 7/31/202210,500 shares $17.64 thousand -34.4%N/A0.1 $1.68 7/15/202216,000 shares $24.16 thousand -67.8%N/A0.1 $1.51 6/30/202249,700 shares $74.55 thousand +100.4%N/A0.3 $1.50 6/15/202224,800 shares $35.96 thousand +113.8%N/A0.2 $1.45 5/31/202211,600 shares $18.33 thousand +4.5%N/A0.1 $1.58 5/15/202211,100 shares $18.65 thousand +40.5%N/A0.1 $1.68 4/30/20227,900 shares $13.97 thousand -69.3%N/A0 $1.77 4/15/202225,700 shares $45.44 thousand +403.9%N/A0.2 $1.77 3/31/20225,100 shares $7.40 thousand +183.3%N/A0 $1.45 3/15/20221,800 shares $3.38 thousand -63.3%N/A0 $1.88 2/28/20224,900 shares $7.94 thousand +444.4%N/A0.1 $1.62 2/15/2022900 shares $1.69 thousand -87.0%N/A0 $1.88 1/31/20226,900 shares $12.66 thousand +165.4%N/A0.1 $1.84 1/15/20222,600 shares $5.54 thousand -78.5%N/A0.1 $2.13 12/31/202112,100 shares $25.77 thousand +656.3%N/A0.2 $2.13 12/15/20211,600 shares $3.30 thousand -89.7%N/A0 $2.06 11/30/202115,500 shares $35.65 thousand +4.0%N/A0.1 $2.30 11/15/202114,900 shares $37.10 thousand +129.2%N/A0 $2.49 10/29/20216,500 shares $15.18 thousand +6,400.0%N/A0 $2.34 10/15/2021100 shares $189.00 -99.4%N/A0 $1.89 9/30/202115,800 shares $29.70 thousand No ChangeN/A0.3 $1.88$100 Trillion “AI Metal” Found in American Ghost Town (Ad)Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.Click here to get the details on this virtual monopoly. 8/31/20211,800 shares $2.97 thousand -73.5%N/A0 $1.65 8/13/20216,800 shares $11.41 thousand +65.9%N/A0.2 $1.68 7/30/20214,100 shares $5.78 thousand +64.0%N/A0.1 $1.41 7/15/20212,500 shares $3.51 thousand No ChangeN/A0 $1.40 6/30/20212,500 shares $3.15 thousand -82.0%N/A0 $1.26 6/15/202113,900 shares $17.24 thousand +195.7%N/A0.1 $1.24 5/28/20214,800 shares $5.23 thousand -11.1%N/A0.3 $1.09 5/14/20215,400 shares $6.35 thousand +42.1%N/A0.2 $1.18 4/30/20213,800 shares $5.40 thousand +65.2%N/A0.1 $1.42 4/15/20212,300 shares $3.13 thousand -79.1%N/A0.1 $1.36 3/31/202111,000 shares $14.70 thousand +746.2%N/A0.3 $1.34 3/15/20211,300 shares $2.01 thousand -50.0%N/A0 $1.55 2/26/20212,600 shares $4.58 thousand -71.7%N/A0.1 $1.76 2/12/20219,200 shares $17.76 thousand +70.4%N/A0.3 $1.93 1/29/20215,400 shares $10.55 thousand +2,600.0%N/A0.1 $1.95 12/31/20202,100 shares $3.56 thousand No ChangeN/A0.1 $1.70 11/30/2020900 shares $1.22 thousand -52.6%N/A0 $1.36 11/15/20201,900 shares $2.72 thousand -5.0%N/A0.1 $1.43 10/30/20202,000 shares $2.48 thousand -59.2%N/A0.1 $1.24 10/15/20204,900 shares $5.28 thousand +1,125.0%N/A0.1 $1.08 9/30/20201,700 shares $1.71 thousand -95.3%N/A0.1 $1.00 9/15/202035,800 shares $29.71 thousand +118.3%N/A0.9 $0.83 8/31/202016,400 shares $10.61 thousand +720.0%N/A1 $0.65 8/14/20202,000 shares $1.26 thousand +81.8%N/A0 $0.63 NGENF Short Interest - Frequently Asked Questions What is NervGen Pharma's current short interest? Short interest is the volume of NervGen Pharma shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 839,700 shares of NGENF short. Learn More on NervGen Pharma's current short interest. What is a good short interest ratio for NervGen Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NGENF shares currently have a short interest ratio of 4.0. Learn More on NervGen Pharma's short interest ratio. Is NervGen Pharma's short interest increasing or decreasing? NervGen Pharma saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 839,700 shares, a decrease of 0.4% from the previous total of 843,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does NervGen Pharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to NervGen Pharma: Hyperion DeFi, Inc. (4.05%), Adial Pharmaceuticals, Inc. (2.29%), Kaleido Biosciences, Inc. (0.16%), Zevra Therapeutics, Inc. (9.07%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short NervGen Pharma stock? Short selling NGENF is an investing strategy that aims to generate trading profit from NervGen Pharma as its price is falling. NGENF shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NervGen Pharma? A short squeeze for NervGen Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NGENF, which in turn drives the price of the stock up even further. How often is NervGen Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NGENF, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Hyperion DeFi Short Interest Data Adial Pharmaceuticals Short Interest Data Kaleido Biosciences Short Interest Data 3SBio Short Interest Data Algernon Pharmaceuticals Short Interest Data ALK-Abelló A/S Short Interest Data Apollomics Short Interest Data Ascentage Pharma Group International Short Interest Data Ascletis Pharma Short Interest Data Avacta Group Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NGENF) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWall Street Hates This Gold IRA Strategy—Here’s WhyWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NervGen Pharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share NervGen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NGENF Stock Alerts